News Posts List
Juby Chacko talks about upcoming patient meetings
02/20/2009
Learn about opportunities to attend local support and education meetings in this YouTube video.
Minimum incision surgeries done through bellybutton
02/19/2009
He and his colleagues want improvements in kidney cancer treatment to be even more meaningful to patients by eliminating the need for any surgery. They are working on ways to freeze the cancer without removing the kidney, as well as looking at using ultrasound and electricity to kill tumors - all without increasing recurrence rates.
Chicago Tea Party - You Can't Buy Prosperity
02/19/2009
The trading floor buzz on whether the government's plan to save the economy will actually help the markets, with Jason Roney, Sharmac Capital; Wilbur Ross Jr., WL Ross & Co. and CNBC's Rick Santelli.
Kidney Cancer News on YouTube
02/19/2009
The latest news of interest to kidney cancer patients, survivors, and their families. Our YouTube videos are also available on social networking sites, such as Facebook and MySpace.
Whole Lotta Hell To Pay
02/18/2009
Lift for Life, an exhibition of strength so fraternally diabolical that it could have been hatched only by football players, is an annual charity event for the Kidney Cancer Association. [Ed note: Paul Posluszny now plays for Buffalo in the NFL]
WILEX reports a successful financial year
02/18/2009
Patient recruitment for the Phase III ARISER trial with RENCAREX(R) in the indication clear cell renal cell carcinoma was completed.
Potential link among caspase-8, p-p38 MAPK and bcl-2 in clear cell renal cell carcinomas
02/17/2009
For the first time the prognostic impact of caspase-8 and p-p38 was studied in a series of ccRCCs, using immunohistochemistry in formalin-fixed and paraffin-embedded tissue sections.
GPC Biotech and Agennix Announce Proposed Merger
02/17/2009
An open label Phase 2 trial in renal cell carcinoma...
Factors Influencing Renal Function Reduction After Partial Nephrectomy
02/16/2009
Renal function following partial nephrectomy is determined by the volume of renal tissue excised, the tumor location and patient age.
AVEO Pharmaceuticals AV-951 Kidney Cancer Drug
02/15/2009
“This Phase 2 trial of AV-951 for the treatment of patients with metastatic renal cell carcinoma (mRCC) exceeded enrollment goals with more than 270 patients participating..."
News Feed